Ascletis Receives $100,000,000 Series B Funding Round

  • Feed Type
  • Date
    1/5/2017
  • Company Name
    Ascletis
  • Mailing Address
    1002 Northridge Lane Chapel Hill, NC 27514 USA
  • Company Description
    Ascletis focuses on building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases.
  • Website
    http://www.ascletis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $100,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Ascletis plans to use the proceeds from this financing to expand its product portfolio and sales force.
  • M&A Terms
  • Venture Investor
    C-Bridge Capital
  • Venture Investor
    Focus Ventures
  • Venture Investor
    Goldman Sachs
  • Venture Investor
    Undisclosed

Trending on Xconomy